Heterocyclic substituted benzothiophenes, compositions, and methods
AssigneeEli Lilly and Company
InventorsGeorge Joseph Cullinan, Kennan Joseph Fahey
Life of this patent
Estimating the term…
Loading patent…
AssigneeEli Lilly and Company
InventorsGeorge Joseph Cullinan, Kennan Joseph Fahey
Estimating the term…
The present invention provides class of compounds of formula I ##STR1## and their pharmaceutically acceptable salts in which R.sup.1 is hydrogen, hydroxy, alkoxy, alkoxycarbonyloxy, alkylcarbonyloxy, arylcarbonyloxy; R.sup.2 is hydrogen, hydroxy, alkoxy, alkoxycarbonyloxy, alkylcarbonyloxy, alkylsulfonyloxy, arylcarbonyloxy, Cl or Br; R.sup.3 and R.sup.4 are independently C.sub.1 -C.sub.4 alkyl, or combine with the nitrogen atom to which they are attached to form a pyrrolidino, piperidino, or hexamethyleneimino ring; X is selected from ##STR2## and Y is --CO--, --CHOH--, or --CH.sub.2 --. The compounds and pharmaceutical compositions containing the compounds, either alone or in combination with either progestin or estrogen, are useful for alleviating the symptoms of osteoporosis, cardiovascular related pathological conditions such as hyperlipidemia, and estrogen-dependent cancer. The compounds of the present invention also are useful for inhibiting uterine fibroid disease and endometriosis in women and aortal smooth muscle cell proliferation, particularly restenosis, in humans.
A compound of formula I ##STR12## or a pharmaceutically acceptable salt thereof wherein R.sup.1 is selected from the group consisting of
Dependencies are inferred from the claim text.